Menu
“With their finger on the pulse of the life science and psychedelic industries, Ambria Capital has been instrumental in Wesana’s early growth. We look forward to building our business relationship and friendship.”
DANIEL CARCILLO
CEO, Wesana Health
Investing in entrepreneurs obsessed with impacting and improving people’s lives.
Ambria Capital is on a mission to empower early-stage companies, in the mental health and technology spaces, that have the ambition and ability to transform markets and make a difference in millions of lives.
Eyes on the frontier
Psychedelics
Digital Health
Cryptocurrency
Cybersecurity
fund focus:
Right now, tens of millions of people are suffering from some form of mental health condition. And the problem is growing worse. Suicide rates are spiking, drug overdoses are at an all-time high and more than half of those affected will receive no treatment. In the current paradigm of care, these numbers will only climb, and this tragedy will never end.
We can help fix it.
The overwhelming success of psychedelics in clinical trials offers people real hope. The scientific evidence is clear that psychedelics far outperform traditional antidepressants and some of these compounds are rapidly approaching regulatory approval. With momentum building and more amazing entrepreneurs emerging across the clinical, manufacturing, and commercial spaces, there is little doubt we are witnessing an awesome mental health revolution and a massive market opportunity.
Psychedelic-assisted therapies are the next major innovation in mental healthcare:
An increasing number of successful clinical trials
FDA breakthrough regulatory designations
Growing capital investment
Evolving public sentiment
We are on the cusp of something incredible. If we can help visionary entrepreneurs fulfill the promise that psychedelics hold, we’ve done our part.
